Neurocrine Biosciences, Inc. (NBIX) Financial Statements

Comprehensive financial analysis for NBIX including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed NBIX financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):39.32

Forward P/E:14.87

EPS (TTM):$3.38

Enterprise Value:$12.70B

Profitability Ratios

Profit Margin:13.88%

Return on Equity:13.39%

Return on Assets:8.67%

Operating Margin:21.18%

Financial Health

Current Ratio:3.20

Quick Ratio:2.88

Debt to Equity:18.18

Beta (5Y):0.25

Revenue and Profit Trends

Growth Metrics

Revenue Growth

16.50%

Earnings Growth

68.30%

Revenue Per Share

$25.12

Performance Metrics

Profit Margin Trend

13.88%

Return on Equity

13.39%

Return on Assets

8.67%

Analyst Insights

Price Targets

Average Target

$167.87

High Target

$200.00

Low Target

$124.00

Analyst Recommendations

Recommendation

Strong Buy

Analyst Coverage

26 Analysts

Upside Potential

+26.3%